World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
32416
World Ranking
13528
National Ranking
6880

Jay S. Skyler publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jay S. Skyler sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 419 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jay S. Skyler D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jay S. Skyler sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jay S. Skyler is affiliated with the University of Miami in the United States and has an extensive research record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields, with a significant focus on Endocrinology, Diabetes and Metabolism, as well as Genetics, Surgery, Immunology, and Infectious Diseases.

The scientist's research topics predominantly involve Diabetes and associated disorders, Diabetes Management and Research, and Pancreatic function and diabetes. Additional focus areas include Diabetes Treatment and Management, Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, and the intersection of Metabolism, Diabetes, and Cancer.

Jay S. Skyler has frequently published in the following venues:

  • Journal of Diabetes
  • Diabetes Care
  • Diabetes
  • Diabetologia
  • The Lancet Diabetes & Endocrinology

Among their recent significant publications are:

  • "Practical recommendations for the management of diabetes in patients with COVID-19" (2020), published in The Lancet Diabetes & Endocrinology
  • "The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" (2021), published in Diabetes Care
  • "The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" (2021), published in Diabetologia
  • "COVID-19 and metabolic disease: mechanisms and clinical management" (2021), published in The Lancet Diabetes & Endocrinology
  • "Novel therapies with precision mechanisms for type 2 diabetes mellitus" (2021), published in Nature Reviews Endocrinology

The scientist maintains collaborative relationships with several frequent co-authors, including Jay M. Sosenko, Juliana C.N. Chan, Heba M. Ismail, Hertzel C. Gerstein, and Zachary T. Bloomgarden, reflecting ongoing research partnerships in their domain.

Best Publications

  • Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association

    Jay S. Skyler;Richard Bergenstal;Robert O. Bonow;John Buse

  • Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.

    Richard A. Insel;Jessica L. Dunne;Mark A. Atkinson;Jane L. Chiang

  • Effects of insulin in relatives of patients with type 1 diabetes mellitus

    J. S. Skyler;D. Brown;H. P. Chase;E. Collier

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Richard I. G. Holt;Richard I. G. Holt;J. Hans DeVries;Amy Hess-Fischl;Irl B. Hirsch

  • An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Kevan C. Herold;Brian N. Bundy;S. Alice Long;Jeffrey A. Bluestone

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • Practical recommendations for the management of diabetes in patients with COVID-19.

    Stefan R. Bornstein;Francesco Rubino;Francesco Rubino;Kamlesh Khunti;Geltrude Mingrone;Geltrude Mingrone

  • Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

    Skyler Js;Krischer Jp;Wolfsdorf J;Cowie C

  • C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21–22 October 2001

    Jerry P. Palmer;G. Alexander Fleming;Carla J. Greenbaum;Kevan C. Herold

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Validation of the insulin sensitivity index (ISI0,120): comparison with other measures ☆

    Miriam Gutt;Catherine L. Davis;Susan B. Spitzer;Maria M. Llabre

  • Insulin action during pregnancy. Studies with the euglycemic clamp technique

    Edmond A Ryan;Mary Jo O'Sullivan;Jay S Skyler

  • Diabetes trends in the USA.

    Jay S. Skyler;Carolyn Oddo

  • The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.

    Jay S. Skyler

  • Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

    Jay S. Skyler;Richard Bergenstal;Robert O. Bonow;John Buse

  • Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

    Jay S. Skyler;William T. Cefalu;Ione A. Kourides;William H. Landschulz

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum

    William T. Cefalu;Sanjay Kaul;Hertzel C. Gerstein;Rury R. Holman

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

Jerry P. Palmer
Jerry P. Palmer University of Washington
Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Desmond A. Schatz
Desmond A. Schatz University of Florida
Kevan C. Herold
Kevan C. Herold Yale University
Neil Schneiderman
Neil Schneiderman University of Miami
Linda A. DiMeglio
Linda A. DiMeglio Indiana University
Antoinette Moran
Antoinette Moran University of Minnesota
Darrell M. Wilson
Darrell M. Wilson Stanford University
Dorothy J. Becker
Dorothy J. Becker University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but want flexible options, numerous online degrees can jumpstart your journey. Many students explore fast track medical programs, such as Licensed Practical Nurse (LPN) pathways, to quickly enter the healthcare workforce. These accelerated courses are ideal for those seeking practical experience and swift employment.

For those aiming to specialize, programs like the fastest psychiatric nurse practitioner program let you become an advanced practice nurse in mental health through a streamlined online curriculum. This is an excellent option for prospective students targeting high-demand specialties.

If your interests lie in leadership or administration, look into earning an online master of health administration. This degree prepares graduates for management roles in clinics, hospitals, and health organizations. Cost is an important factor, so it’s wise to compare programs based on tuition and fees, as highlighted in this guide on masters in healthcare administration cost.

Online healthcare degrees offer flexibility and diverse career pathways, making them a practical option for aspiring medical professionals. Explore the available programs to find the path that best matches your goals.

Best Scientists Citing Jay S. Skyler

Trending Scientists

Recently Published Articles